¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"restriction analysis"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
asymmetric fetal growth restriction
ºñ´ëĪžƼºÀåÁ¦ÇÑ
genetic restriction
À¯Àü»óÈ£ÀÛ¿ëÁ¦ÇÑ
intrauterine growth restriction
Àڱ󻼺ÀåÁ¦ÇÑ
restriction
Á¦ÇÑ
restriction endonuclease
Á¦ÇÑÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑ¿£µµ´ºÅ¬·¹¾ÆÁ¦
restriction enzyme
Á¦ÇÑÈ¿¼Ò
restriction fragment length polymorphism
Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
restriction map
Á¦ÇÑÈ¿¼ÒÁöµµ
antigen analysis
Ç׿øºÐ¼®
arterial blood gas analysis
µ¿¸ÆÇ÷°¡½ººÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
age-period cohort analysis
¿¬·É±â°£ÄÚȣƮºÐ¼®
analysis
ºÐ¼®
birth cohort analysis
Ãâ»ýÄÚȣƮºÐ¼®
clinical decision analysis
ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
restriction enzyme
Á¦ÇÑÈ¿¼Ò
restriction map
Á¦ÇÑÈ¿¼ÒÁöµµ
restriction
Á¦ÇÑ
intrauterine growth restriction
Àڱ󻼺ÀåÁö¿¬
salt restriction
¿°ºÐÁ¦ÇÑ
water restriction
¹°Á¦ÇÑ, ¼öºÐÁ¦ÇÑ
analysis
ºÐ¼®
antigen analysis
Ç׿øºÐ¼®
path analysis
°æ·ÎºÐ¼®
qualitative analysis
Á¤¼ººÐ¼®
quantitative analysis
Á¤·®ºÐ¼®
statistical analysis
Åë°èºÐ¼®
survival analysis
»ýÁ¸ºÐ¼®
system analysis
°èÅëºÐ¼®
meta-analysis
¸ÞŸºÐ¼®
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
restriction endonuclease
Á¦ÇÑÀûÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑÀû¿£µµ´ºÅ¬·¹¾ÆÁ¦
restriction enzyme
Á¦ÇÑÈ¿¼Ò
genetic restriction
À¯ÀüÀû»óÈ£ÀÛ¿ëÁ¦ÇÑ
haplotype restriction
ÀϹè¼öüÁ¦ÇÑ
restriction map
Á¦ÇÑÈ¿¼ÒÁöµµ
restriction fragment length polymorphism
Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
restriction
Á¦ÇÑ
restriction endonuclease
Á¦ÇÑÇٻ곻ºÎ°¡¼öºÐÇØÈ¿¼Ò
sleep position restriction
¼ö¸éÀÚ¼¼Á¦ÇÑ
analysis
ºÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
age-period cohort analysis
¿¬·É±â°£ÄÚȣƮºÐ¼®
antigen analysis
Ç׿øºÐ¼®
birth cohort analysis
Ãâ»ýÄÚȣƮºÐ¼®
case analysis
Áõ·ÊºÐ¼®
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
Ia restriction
IaÂ÷À̼ö¹Ý ¸é¿ª»óÈ£ÀÛ¿ëÁ¦ÇÑ
haplotype restriction
ÁÖÁ¶Á÷ÀûÇÕÇ׿øº¹ÇÕü¿°»öü Â÷À̼ö¹Ý ¸é¿ªÁ¦ÇÑ
homologous restriction factor
µ¿Á¾Á¦ÇÑÀÎÀÚ
DNA sequence analysis
DNA ¼¿ºÐ¼®
Data analysis
Á¤º¸ºÐ¼®
Decision analysis
°áÁ¤ºÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®(¡ÝÂà°), ¹æ»çÈ(Û¯ÞÒûù)ºÐ¼®.
activation analysis
¹æ»çȺм®, Ȱ¼ºÈºÐ¼®
amniotic fluid analysis
¾ç¼öºÐ¼®
analysis
ºÐ¼®
analysis of variance technique
ºÐ»ê±â¼úºÐ¼®
analysis, antigen
Ç׿øºÐ¼®
frequency analysis
Á֯ļöºÐ¼®
gas analysis
°¡½ººÐ¼®.
gas analysis
°¡½ººÐ¼®
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
restriction analysis
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
restriction fragment length polymorphism analysis
Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
endonuclease, restriction
Á¦ÇÑÈ¿¼Ò
enzyme, restriction
Á¦ÇÑÈ¿¼Ò
haplotype restriction
ÁÖÁ¶Á÷ÀûÇÕÇ׿øº¹ÇÕü¿°»öü Â÷À̼ö¹Ý ¸é¿ªÁ¦ÇÑ
homologous restriction factor
µ¿Á¾Á¦ÇÑÀÎÀÚ
legal restriction
¹ýÀûÇѰè(¡ùÚÍ£).
legal restriction
¹ýÀûÇѰè(ÊṴ̀Ë).
mst ii restriction enzyme
Mst II Á¦ÇÑÈ¿¼Ò(¡ ð¤ùÚý£áÈ)
restriction endonuclease
Á¦ÇÑ¿£µµ´ºÅ¬¸®¿¡ÀÌÁî
restriction endonuclease
Á¦ÇÑÈ¿¼Ò
restriction endonucleases
Á¦ÇÑÇÙ»ê ³»ºÎ°¡¼öºÐÇØÈ¿¼Ò
restriction enzyme
Á¦ÇÑÈ¿¼Ò
restriction enzyme
Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ).
restriction enzymes
Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ)
restriction fragment length polymorphism
Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡Òýû¡à÷)
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½